CellsBin
CompanyUnited States· Diagnostics
US biotech building a rare-cell analysis platform.
Minutes holds 1 development and 1 deal naming CellsBin, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| CellsBinDiagnostics | FundingSeries A | Not recorded | Led by 108 BioCapital | 22 Sep | Closed |